+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 19Years +
All Genders
ID06186037

Comparison of Low-dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin for Patients with Mild to Moderate Coronary Artery Disease Without Previous Coronary Procedures

Led by Saint Vincent's Hospital, Korea · Updated on 2025-06-25

6356

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are comparing two cholesterol-lowering treatments in patients with minimal to intermediate coronary artery disease who have not had percutaneous coronary intervention. The study aims to see if a combination of low-dose rosuvastatin and ezetimibe is not worse than high-dose rosuvastatin alone in reducing major heart-related events. This is important because high-dose statins can cause side effects, especially in East Asian patients, and the combination might reduce these risks while still lowering LDL cholesterol effectively. The study will include 6,356 patients randomly assigned to one of two groups one group will take ezetimibe 10 mg combined with rosuvastatin 5 mg once daily, and the other will take rosuvastatin 20 mg once daily. Both treatments will be taken for three years. Follow-up visits to monitor progress will happen at 6 weeks, 6 months, 12 months, and 36 months after starting treatment. Follow-up can be done in person or by phone. Participants will have their health assessed at these visits to monitor for important events such as death, heart attacks, strokes, hospitalizations due to unstable angina, and procedures to improve blood flow to the heart. Researchers will track these combined outcomes over 36 months. Safety and treatment effects will be carefully observed throughout the study period, which runs until 2029.

CONDITIONS

Brief Title

Clinical Comparison of Low-dose Rosuvastatin Plus Ezetimibe Combination Therapy and High-dose Rosuvastatin Monotherapy in Patients With Minimal to Intermediate Coronary Artery Disease Without Percutaneous Coronary Intervention

Research Team

S

Sung-ho Her, MD.PhD

J

Jung Jin, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here